Nigerians living with HIV will soon heave a new sigh of relief as UNIAID, a global health initiative working with partners to end tuberculosis, HIV/AIDS and malaria epidemic, will soon roll out a generic version of the latest AIDS drug called Dolutegravir (DTG) already recording success in Kenya.
U
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Anthonia Obokoh
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
